AML-284 Venetoclax in Combination With Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia: Clinical Experience From a Real-Life Setting

Clinical Lymphoma, Myeloma and Leukemia - Tập 23 - Trang S285-S286 - 2023
Matteo Piccini1, Giacomo Gianfaldoni1, Francesco Mannelli2,3, Barbara Scappini1, Gaia Ciolli2, Andrea Pasquini2, Laura Fasano2, Sofia Pilerci2, Elisa Quinti2, Francesca Crupi2, Paola Guglielmelli2,3, Alessandro Maria Vannucchi2,3
1Hematology Department, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
2Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy
3CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy

Thông tin
Thông tin xuất bản

Clinical Lymphoma, Myeloma and Leukemia

Tập 23

S285-S286

Thông tin tác giả